Diets for patients with cystic fibrosis

被引:0
|
作者
Wächtershäuser, A [1 ]
Bargon, JG [1 ]
Stein, J [1 ]
机构
[1] Zentrum Innere Med, D-60590 Frankfurt, Germany
来源
ERNAHRUNGS-UMSCHAU | 2002年 / 49卷 / 10期
关键词
cystic fibrosis; malnutrition; nutritional therapy; patient's diet;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Cystic fibrosis (CF) is a disease caused by a genetic disorder which is associated with an impaired transport of electrolytes in the secretory epithelium of excretory glands. This autosomal recessive hereditary disease is a multiorgan disease, characterized mainly by respiratory but also by digestive malfunctions and often linked with malnutrition. Malnutrition is due to a disturbed energy balance caused by reduced energy supply (maldigestion and malabsorption as a result of exocrine pancreas insufficiency, lack of appetite, nausea and vomiting) and an increased energy need (infections, fever, increased respiration). Nutritional therapy and supplementation of pancreatic enzymes are effective means of influencing the extent of malnutrition and deterioration of lung function. The diet of CF patients should be well balanced and fat-supplemented. in addition, the status of vitamins, minerals and trace elements should be checked regularly and individual nutrients be supplemented, if necessary. The use of nutritional supplements may be beneficial for undernourished patients to significantly increase their weight index. In severe cases of malnutrition enteral or parenteral nutrition should be considered.
引用
收藏
页码:380 / +
页数:7
相关论文
共 50 条
  • [1] Sleep screening for cystic fibrosis patients: A survey of cystic fibrosis programs
    Thomas, Caroline S.
    Brown, Rebekah F.
    [J]. PEDIATRIC PULMONOLOGY, 2020, 55 (12) : 3358 - 3363
  • [2] Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?
    Costa Brzezinski, Lorena Xavier
    Riedi, Carlos Antonio
    Kussek, Paulo
    de Melo de Souza, Helena Homem
    Rosario, Nelson
    [J]. JORNAL BRASILEIRO DE PNEUMOLOGIA, 2011, 37 (03) : 341 - 347
  • [3] Cystic fibrosis transmembrane regulator haplotypes in households of patients with cystic fibrosis
    Furgeri, Daniela Tenorio
    Lima Marson, Fernando Augusto
    Araujo Correia, Cyntia Arivabeni
    Ribeiro, Jose Dirceu
    Bertuzzo, Carmen Silvia
    [J]. GENE, 2018, 641 : 137 - 143
  • [4] Cystic fibrosis mutations and associated haplotypes in Turkish cystic fibrosis patients
    Onay, T
    Zielenski, J
    Topaloglu, O
    Gokgoz, N
    Kayserili, H
    Apak, MY
    Camcioglu, Y
    Cokugras, H
    Akcakaya, N
    Tsui, LC
    Kirdar, B
    [J]. HUMAN BIOLOGY, 2001, 73 (02) : 191 - 203
  • [5] When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
    Faro, Albert
    Goss, Christopher
    Cromwell, Elizabeth
    Elbert, Alex
    Brown, Anne W.
    Marshall, Bruce C.
    [J]. RESPIRATORY MEDICINE, 2022, 193
  • [6] First report of cystic fibrosis mutations in Libyan cystic fibrosis patients
    Fredj, Sondess Hadj
    Fattoum, Slaheddine
    Chabchoub, Abdelraouf
    Messaoud, Taieb
    [J]. ANNALS OF HUMAN BIOLOGY, 2011, 38 (05) : 561 - 563
  • [7] MRSA in patients with cystic fibrosis
    Estrada, B
    [J]. INFECTIONS IN MEDICINE, 2004, 21 (01) : 13 - 13
  • [8] Vaccination of cystic fibrosis patients
    Iordache, L.
    Gaudelus, J.
    Hubert, D.
    Launay, O.
    [J]. ARCHIVES DE PEDIATRIE, 2012, 19 : S36 - S39
  • [9] Proteinuria in patients with cystic fibrosis
    Kuwertz-Bröking, E
    Koch, HG
    Schulze-Everding, A
    Helmchen, U
    Bulla, M
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 1998, 146 (11) : 1044 - 1049
  • [10] Pain in cystic fibrosis patients
    van Koningsbruggen, S.
    Tinschmann, T.
    Doehmen, H.
    Griese, M.
    Heuer, E.
    Kappler, M.
    Koester, H.
    Nuesslein, T.
    Sorichter, S.
    Staab, D.
    Rietschel, E.
    [J]. PEDIATRIC PULMONOLOGY, 2007, : 406 - 406